首页 | 本学科首页   官方微博 | 高级检索  
     


Comparison between nafarelin acetate andd-Trp6-LHRH for temporary pituitary suppression in in vitro fertilization (IVF) patients: A prospective crossover study
Authors:Vasilios Tanos  Shevach Friedler  Asher Shushan  Nurith Strauss  Iftach Hetsroni  Aby Lewin
Affiliation:(1) Department of Obstetrics and Gynecology, Hadassah University Hospital, Ein-Kerem, Jerusalem;(2) Department of Obstetrics and Gynecology, Hadassah Medical Center, Ein-Kerem, P.O. Box 12000, il-91120 Jerusalem, Israel
Abstract:
Purpose Nafarelin acetate is a new gonadotropin releasing (GnRH) agonist analogue with unique potency, intranasal administration, and convenient storage. Hence, nafarelin was considered as an alternative for temporary pituitary suppression in patients undergoing ovulation induction in IVF. A crossover treatment in a prospective study was performed including 40 women with bilateral obstructed tubes and normal ovarian function, treated in 80 ovulation induction cycles using the long protocol. Twenty patients used nafarelin acetate 600 Mgrg/daily in their first cycle and receivedd-Trp6-LHRH, 0.5 mg/daily, in their following cycle. The other 20 women used decapeptyl in their first cycle and received nafarelin in the second.Results Estradiol suppression was achieved by bothd-Trp6-LHRH and nafarelin at equal time intervals. The average total number of ampoules (P=0.0005) and the length of administration of hMG required for ovarian stimulation (P=0.0002) and the time interval between GnRHa initiation to oocyte retrieval (P=0.04) was significantly lower in nafarelin cycles. The number and the distribution between large and small follicles as well as the average number of oocytes retrieved did not differ between the two GnRH analogues.Conclusion Our results demonstrate that nafarelin acetate is comparable tod-Trp6-LHRH for temporary pituitary suppression used for controlled ovarian stimulation in IVF patients. However, using nafarelin ovarian stimulation was achieved with fewer ampoules of hMG, administered for a shorter period of time, thus with a lesser cost.
Keywords:nafarelin acetate  gonadotropin releasing hormone analogues  controlled ovarian stimulation  in vitro fertilization  pituitary suppression
本文献已被 SpringerLink 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号